Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism

Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hong Lyeol, Kim, Lucia, Kim, Cheol Woo, Kim, Jung Soo, Nam, Hae Sung, Ryu, Jeong Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356047/
https://www.ncbi.nlm.nih.gov/pubmed/30740299
http://dx.doi.org/10.1016/j.rmcr.2019.01.017
_version_ 1783391451477966848
author Lee, Hong Lyeol
Kim, Lucia
Kim, Cheol Woo
Kim, Jung Soo
Nam, Hae Sung
Ryu, Jeong Seon
author_facet Lee, Hong Lyeol
Kim, Lucia
Kim, Cheol Woo
Kim, Jung Soo
Nam, Hae Sung
Ryu, Jeong Seon
author_sort Lee, Hong Lyeol
collection PubMed
description Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternatives, because of their efficacy and safety. In this case report, we describe a case of leukocytoclastic vasculitis induced by both rivaroxaban- and dabigatran-, which developed during the management of pulmonary thromboembolism.
format Online
Article
Text
id pubmed-6356047
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63560472019-02-08 Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism Lee, Hong Lyeol Kim, Lucia Kim, Cheol Woo Kim, Jung Soo Nam, Hae Sung Ryu, Jeong Seon Respir Med Case Rep Case Report Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternatives, because of their efficacy and safety. In this case report, we describe a case of leukocytoclastic vasculitis induced by both rivaroxaban- and dabigatran-, which developed during the management of pulmonary thromboembolism. Elsevier 2019-01-25 /pmc/articles/PMC6356047/ /pubmed/30740299 http://dx.doi.org/10.1016/j.rmcr.2019.01.017 Text en © 2019 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Lee, Hong Lyeol
Kim, Lucia
Kim, Cheol Woo
Kim, Jung Soo
Nam, Hae Sung
Ryu, Jeong Seon
Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
title Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
title_full Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
title_fullStr Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
title_full_unstemmed Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
title_short Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
title_sort case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356047/
https://www.ncbi.nlm.nih.gov/pubmed/30740299
http://dx.doi.org/10.1016/j.rmcr.2019.01.017
work_keys_str_mv AT leehonglyeol caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism
AT kimlucia caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism
AT kimcheolwoo caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism
AT kimjungsoo caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism
AT namhaesung caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism
AT ryujeongseon caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism

Ejemplares similares